Advertisement

Mechanisms of Anaphylaxis

  • Stephen F. Kemp
  • Richard F. Lockey
Part of the Allergy Frontiers book series (ALLERGY, volume 3)

Abstract

Anaphylaxis is a life-threatening syndrome resulting from the sudden release of mast cell- and basophil-derived mediators into the circulation. Foods and medications cause most anaphylaxis for which a cause can be identified, but virtually any agent capable of directly or indirectly activating mast cells or basophils can cause this syndrome. This review discusses the pathophysiologic mechanisms of anaphylaxis.

Keywords

Mast Cell Platelet Activate Factor Allergy Clin Immunol Anaphylactic Shock World Allergy Organization 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Sampson HA, Muñoz-Furlong A, Campbell RL, et al. (2006) Second symposium on the definition and management of anaphylaxis: summary report. J Allergy Clin Immunol 117: 391–7.PubMedCrossRefGoogle Scholar
  2. 2.
    Kemp SF, Lockey RF (2002) Anaphylaxis: a review of causes and mechanisms. J Allergy Clin Immunol 110:341–8.PubMedCrossRefGoogle Scholar
  3. 3.
    Pumphrey R (2004) Anaphylaxis: can we tell who is at risk of a fatal reaction? Curr Opin Allergy Clin Immunol 4:285–90.PubMedCrossRefGoogle Scholar
  4. 4.
    Johansson SGO, Bieber T, Dahl R, et al. (2004) Revised nomenclature for allergy for global use: report of the Nomenclature Review Committee of the World Allergy Organization, October 2003. J Allergy Clin Immunol 113:832–6.PubMedCrossRefGoogle Scholar
  5. 5.
    Coombs RRA, Gell PGH (1975) Classification of allergic reactions responsible for clinical hypersensitivity and disease. In: Gell PGH, Coombs RRA, Lachmann PJ (eds) Clinical Aspects of Immunology, 3rd ed. Blackwell Scientific, Oxford, pp. 761–81.Google Scholar
  6. 6.
    Sell S (1996) Immunopathology. In: Rich RR, Fleisher TA, Schwartz BD, Shearer WT, Strober W (eds) Clinical Immunology: Principles and Practice. Mosby, St. Louis, MO, pp. 449–77.Google Scholar
  7. 7.
    Finkelman FD, Rothenberg ME, Brandt EB, et al. (2005) Molecular mechanisms of anaphy-laxis: lessons from studies with murine models. J Allergy Clin Immunol 115:449–57.PubMedCrossRefGoogle Scholar
  8. 8.
    Strait RT, Morris SC, Finkelman FD (2006) IgG blocking antibodies inhibit IgE-mediated anaphylaxis in vivo through both antigen interruption and FcγRIIb cross-linking. J Clin Invest 116:833–41.PubMedCrossRefGoogle Scholar
  9. 9.
    Goetzl EJ, Wasserman SI, Austin KF (1975) Eosinophil polymorphonuclear leukocyte function in immediate hypersensitivity. Arch Pathol 99:1–4.PubMedGoogle Scholar
  10. 10.
    Lieberman P (2003) Anaphylaxis and anaphylactoid reactions. In: Adkinson NF Jr, Yunginger JW, Busse WW, et al. (eds) Middleton's Allergy: Principles and Practice, 6th ed. Mosby-Year Book, St. Louis, MO, pp. 1497–1522.Google Scholar
  11. 11.
    Erjefält JS, Korsgren M, Malm-Erjefält M, et al. (2003) Acute allergic responses induce a prompt luminal entry of airway tissue eosinophils. Am J Respir Cell Mol Biol 29:439–48.PubMedCrossRefGoogle Scholar
  12. 12.
    Kaliner M, Sigler R, Summers R, Shelhamer JH (1981) Effects of infused histamine: analysis of the effects of H-1 and H-2 receptor antagonists on cardiovascular and pulmonary responses. J Allergy Clin Immunol 68:365–71.PubMedCrossRefGoogle Scholar
  13. 13.
    Chrusch C, Sharma S, Unruh H, Bautista E, Duke E, Becker A, et al. (1999) Histamine H3 receptor blockade improves cardiac function in canine anaphylaxis. Am J Respir Crit Care Med 160:142–9.Google Scholar
  14. 14.
    Schwartz LB (2004) Effector cells of anaphylaxis: mast cells and basophils. Novartis Found Symp 257:65–74.PubMedCrossRefGoogle Scholar
  15. 15.
    Yunginger JW, Nelson DR, Squillace DL, et al. (1991) Laboratory investigations of death due to anaphylaxis. J Forensic Sci 36:857–65.PubMedGoogle Scholar
  16. 16.
    Lin RY, Schwartz LB, Curry A, et al. (2000) Histamine and tryptase levels in patients with acute allergic reactions: an emergency department-based study. J Allergy Clin Immunol 106:65–71.PubMedCrossRefGoogle Scholar
  17. 17.
    Smith PL, Kagey-Sobotka A, Bleecker ER, Traystman R, Kaplan AP, Gralnick H, et al. (1980) Physiologic manifestations of human anaphylaxis. J Clin Invest 66:1072–80.PubMedCrossRefGoogle Scholar
  18. 18.
    Pumphrey RS, Roberts IS (2000) Postmortem findings after fatal anaphylactic reactions. J Clin Pathol 53:273–6.PubMedCrossRefGoogle Scholar
  19. 19.
    Ansari MQ, Zamora JL, Lipscomb MF (1993) Postmortem diagnosis of acute anaphylaxis by serum tryptase analysis. A case report. Am J Clin Pathol 99:101–3.PubMedGoogle Scholar
  20. 20.
    Schwartz HJ, Yunginger JW, Schwartz LB (1995) Is unrecognized anaphylaxis a cause of sudden unexpected death? Clin Exp Allergy 25:866–70.PubMedCrossRefGoogle Scholar
  21. 21.
    Platt MS, Yunginger JW, Sekula-Perlman A, Irani AM, et al. (1994) Involvement of mast cells in sudden infant death syndrome. J Allergy Clin Immunol 94:250–6.PubMedCrossRefGoogle Scholar
  22. 22.
    Randall B, Butts J, Halsey JF (1995) Elevated postmortem tryptase in the absence of anaphy-laxis. J Forensic Sci 40:208–11.PubMedGoogle Scholar
  23. 23.
    Edston E, van Hage-Hamsten M (1998) α-Tryptase measurements post-mortem in anaphylac-tic deaths and in controls. Forensic Sci Int 93:135–42.PubMedCrossRefGoogle Scholar
  24. 24.
    Edston E, Gidlund E, Wickman M, Ribbing H, van Hage-Hamsten M (1999) Increased mast cell tryptase in sudden infant death – anaphylaxis, hypoxemia or artifact? Clin Exp Allergy 29:1648–54.PubMedCrossRefGoogle Scholar
  25. 25.
    Palmer RMJ, Ferrige AG, Moncada S (1987) Nitric oxide release accounts for the biological activity of endothelium derived relaxing factor. Nature 327:524–6.PubMedCrossRefGoogle Scholar
  26. 26.
    Coleman JW (2002) Nitric oxide: a regulator of mast cell activation and mast cell-mediated inflammation. Clin Exp Immunol 129:4–10.PubMedCrossRefGoogle Scholar
  27. 27.
    Mitsuhata H, Shimizu R, Yokoyama MM (1995) Role of nitric oxide in anaphylactic shock. J Clin Immunol 15:277–83.PubMedCrossRefGoogle Scholar
  28. 28.
    Lowenstein CJ, Michel T (2006) What's in a name? eNOS and anaphylactic shock. J Clin Invest 116:2075–8.PubMedCrossRefGoogle Scholar
  29. 29.
    Cauwels A, Janssen B, Buys E, et al. (2006) Anaphylactic shock depends on PI3K and eNOS-derived NO. J Clin Invest 116:2244–51.PubMedCrossRefGoogle Scholar
  30. 30.
    Windbichler M, Echtenacher B, Takahashi K, et al. (2006) Investigations on the involvement of the lectin pathway of complement activation in anaphylaxis. Int Arch Allergy Immunol 141:11–23.PubMedCrossRefGoogle Scholar
  31. 31.
    van der Linden P-WG, Struyvenberg A, Kraaijenhagen RJ, Hack CE, van der Zwan JK (1993) Anaphylactic shock after insect-sting challenge in 138 persons with a previous insect-sting reaction. Ann Intern Med 118:161–8.PubMedGoogle Scholar
  32. 32.
    Kaplan AP, Joseph K, Silverberg M (2002) Pathways for bradykinin formation and inflammatory disease. J Allergy Clin Immunol 109:195–209.PubMedCrossRefGoogle Scholar
  33. 33.
    James LP Jr, Austen KF (1964) Fatal and systemic anaphylaxis in man. N Engl J Med 270:597–603.PubMedCrossRefGoogle Scholar
  34. 34.
    Warren S, Dixon FJ (1948) Antigen tracer studies and histologic observations in anaphylactic shock in the guinea pig. Part 1. Am J Med Sci 216:136–45.PubMedCrossRefGoogle Scholar
  35. 35.
    Lockey RF, Bukantz SC (1974) Allergic emergencies. Med Clin North Am 58:147–56.PubMedGoogle Scholar
  36. 36.
    Coca AF (1919) The mechanism of the anaphylaxis reaction in the rabbit. J Immunol 4:219–31.Google Scholar
  37. 37.
    Greenberger PA, Rotskoff BD, Lifschultz B (2007) Fatal anaphylaxis: postmortem findings and associated comorbid diseases. Ann Allergy Asthma Immunol 98:252–7.PubMedCrossRefGoogle Scholar
  38. 38.
    Raper RF, Fisher MM (1988) Profound reversible myocardial depression after anaphylaxis. Lancet 1:386–8.PubMedCrossRefGoogle Scholar
  39. 39.
    Bristow MR, Ginsburg R, Harrison DC (1982) Histamine and the human heart: the other receptor system. Am J Cardiol 49:249–51.PubMedCrossRefGoogle Scholar
  40. 40.
    Marone G, Bova M, Detoraki A, et al. (2004) The human heart as a shock organ in anaphy-laxis. Novartis Found Symp 257:133–49.PubMedCrossRefGoogle Scholar
  41. 41.
    Wittstein IS, Thiemann DR, Lima JAC, et al. (2005) Neurohumoral features of myocardial stunning due to sudden emotional stress. N Engl J Med 352:539–48.PubMedCrossRefGoogle Scholar
  42. 42.
    Pumphrey RS (2003) Fatal posture in anaphylactic shock. J Allergy Clin Immunol 112:451–2.PubMedGoogle Scholar
  43. 43.
    Fisher MM (1986) Clinical observations on the pathophysiology and treatment of anaphylac-tic cardiovascular collapse. Anaesth Intensive Care 14:17–21.PubMedGoogle Scholar
  44. 44.
    Hermann K, Rittweger R, Ring J (1992) Urinary excretion of angiotensin I, II, arginine vaso-pressin and oxytocin in patients with anaphylactoid reactions. Clin Exp Allergy 22:845–53.PubMedCrossRefGoogle Scholar
  45. 45.
    von Tschirschnitz M, von Eschenbach CE, Hermann K, Ring J (1993) Plasma angiotensin II in patients with Hymenoptera venom allergy during hyposensitization [abstract]. J Allergy Clin Immunol 91:283.Google Scholar
  46. 46.
    Hanashiro PK, Weil MH (1967) Anaphylactic shock in man: report of two cases with detailed hemodynamics and metabolic studies. Arch Intern Med 119:129–40.PubMedCrossRefGoogle Scholar
  47. 47.
    Fahmy NR (1981) Hemodynamics, plasma histamine and catecholamine concentrations during an anaphylactoid reaction to morphine. Anesthesiology 55:329–31.PubMedCrossRefGoogle Scholar
  48. 48.
    Kovanen PT, Kaartinen M, Paavonen T (1995) Infiltrates of activated mast cells at the site of coronary atheromatous erosion or rupture in myocardial infarction. Circulation 92:1084–8.PubMedGoogle Scholar
  49. 49.
    Kounis NG (2006) Kounis syndrome (allergic angina and allergic myocardial infarction): a natural paradigm? Int J Cardiol 110:7–14.PubMedCrossRefGoogle Scholar
  50. 50.
    Abela GS, Picon PD, Friedl SE, Gebara OC, Miyamoto A, Federman M, et al. (1995) Triggering of plaque disruption and arterial thrombosis in an atherosclerotic rabbit model. Circulation 91:776–84.PubMedGoogle Scholar
  51. 51.
    Steffel J, Akhmedov A, Greutert H, et al. (2005) Histamine induces tissue factor expression: implications for acute coronary syndromes. Circulation 112:341–9.PubMedCrossRefGoogle Scholar
  52. 52.
    Rubin LE, Levi R (1995) Protective role of bradykinin in cardiac anaphylaxis: coronary-vasodilating and antiarrhythmic activities mediated by autocrine/paracrine mechanisms. Circulation Research 76:434–40.PubMedGoogle Scholar
  53. 53.
    Schuligoi R, Amann R, Donnerer J, Peskar BA (1997) Release of calcitonin gene-related peptide in cardiac anaphylaxis. Naunyn-Schmiedeberg's Arch Pharmacol 355:224–9.CrossRefGoogle Scholar
  54. 54.
    Rang WQ, Du YH, Hu CP, et al. (2003) Protective effects of calcitonin gene-related peptide-mediated evodiamine on guinea-pig cardiac anaphylaxis. Naunyn-Schmiedeberg's Arch Pharmacol 367:306–11.CrossRefGoogle Scholar
  55. 55.
    Brown SGA, Blackman KE, Stenlake V, Heddle RJ (2004) Insect sting anaphylaxis: prospective evaluation of treatment with intravenous adrenaline and volume resuscitation. Emerg Med J 21:149–54.PubMedCrossRefGoogle Scholar
  56. 56.
    Schadt JC, Ludbrook J (1991) Hemodynamic and neurohumoral responses to acute hypovo-lemia in conscious mammals. Am J Physiol 260:H305–18.PubMedGoogle Scholar
  57. 57.
    Demetriades D, Chan LS, Bhasin P, et al. (1998) Relative bradycardia in patients with traumatic hypotension. J Trauma 45:534–9.PubMedCrossRefGoogle Scholar

Copyright information

© Springer 2009

Authors and Affiliations

  • Stephen F. Kemp
    • 1
  • Richard F. Lockey
    • 2
  1. 1.Division of Clinical Immunology and Allergy, Department of MedicineThe University of Mississippi Medical CenterJacksonUSA
  2. 2.Division of Allergy and Immunology, Department of Internal MedicineUniversity of South Florida College of Medicine and the James A. Haley Veterans Administration HospitalTampaUSA

Personalised recommendations